Legislative Advocacy

Finish the Fight: Push for PBM Reform in the Final Lame Duck Session of Congress [...]

Part D open enrollment is here, with 2025 bringing changes to lower drug costs and impact IPC members.

In this special episode, we discuss the Pharmacists Fight Back Act and explore Ohio's pivotal role in advancing PBM reform.

IPC hosted Senator Tammy Baldwin to discuss pharmacy reforms and showcase their distribution operations.

The FTC report exposes PBMs for inflating drug costs and harming independent pharmacies through unfair practices.

Finish the fight for PBM reform. Engage patients with resources to message their elected officials.

IPC and a coalition of pharmacy organizations released a statement before Tuesday's U.S. House Oversight hearing on PBM tactics.

FTC's July 2024 report reveals PBMs inflating drug costs, squeezing community pharmacies, and impacting patient access.

The FDA has announced critical updates on the implementation of the Drug Supply Chain Security Act (DSCSA).

IPC champions community pharmacies in pivotal Ohio case.